Tandem climbs on $36 million settlement agreement with Roche
Shares of medical device maker Tandem Diabetes Care TNDM.O rise 3.8% to $21.50 in extended trading
Company says it entered into a settlement agreement with Roche ROG.S to resolve patent disputes related to TNDM's insulin pump, t:slim X2
TNDM will pay Roche $36 million over a five-year period, with an initial payment of $8 million as part of the settlement
Up to last close, TNDM down 42.5% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

Gold Price Forecast: U.S.-Iran Tensions Ease, Nonfarm Payrolls Looming, What’s Next for Gold?

SpaceX IPO Approaches: Musk Dissolves xAI into SpaceX and Subleases 300MW Compute to Anthropic; Can the $2 Trillion Valuation Hold?

WTI and Brent Futures Both Fall Below $100 Mark, Have Oil Prices and Energy Sector Peaked?

Tradingkey








